We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+8.72%
1 Year Est. Return
+18.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$58.1M
AUM Growth
-$17.9M
Cap. Flow
-$21M
Cap. Flow %
-36.15%
Top 10 Hldgs %
43.93%
Holding
340
New
63
Increased
59
Reduced
56
Closed
151

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$5.02M
2
AKBA icon
Akebia Therapeutics
AKBA
+$3.63M
3
FL
Foot Locker
FL
+$2.12M
4
GIS icon
General Mills
GIS
+$2.03M
5
LULU icon
lululemon athletica
LULU
+$1.38M

Sector Composition

Rank Sector Weight
1 Healthcare 43.07%
2 Miscellaneous 34.08%
3 Consumer Staples 17.11%
4 Consumer Discretionary 2.69%
5 Communication Services 1.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
226
CALL
Alphabet (Google) Class A
GOOGL
$4.14T
-10,000
Closed -$11K
GOOGL icon
227
Alphabet (Google) Class A
GOOGL
$4.14T
-6,000
Closed -$254K
GOOGL icon
228
PUT
Alphabet (Google) Class A
GOOGL
$4.14T
-30,000
Closed -$28K
IBM icon
229
IBM
IBM
$221B
-3,173
Closed -$528K
IBM icon
230
PUT
IBM
IBM
$221B
-10,460
Closed -$14K
INFY icon
231
Infosys
INFY
$47.4B
-6,170
Closed -$46.2K
INFY icon
232
PUT
Infosys
INFY
$47.4B
-39,200
Closed -$4K
ISRG icon
233
Intuitive Surgical
ISRG
$130B
-7,704
Closed -$740K
JNJ icon
234
CALL
Johnson & Johnson
JNJ
$663B
-53,000
Closed -$120K
JNJ icon
235
PUT
Johnson & Johnson
JNJ
$663B
-57,500
Closed -$27K
LGND icon
236
Ligand Pharmaceuticals
LGND
$5.69B
-5,740
Closed -$379K
LGND icon
237
PUT
Ligand Pharmaceuticals
LGND
$5.69B
-32,060
Closed -$26K
LULU icon
238
lululemon athletica
LULU
$11.1B
-26,500
Closed -$1.38M
LULU icon
239
PUT
lululemon athletica
LULU
$11.1B
-31,600
Closed -$477K
M icon
240
CALL
Macy's
M
$6.06B
-16,100
Closed -$13K
META icon
241
CALL
Meta Platforms (Facebook)
META
$1.57T
-20,000
Closed -$16K
MNST icon
242
CALL
Monster Beverage
MNST
$85.8B
-20,000
Closed -$10K
MNST icon
243
Monster Beverage
MNST
$85.8B
-12,000
Closed -$139K
MNST icon
244
PUT
Monster Beverage
MNST
$85.8B
-90,000
Closed -$38K
MSFT icon
245
CALL
Microsoft
MSFT
$3.71T
-7,500
Closed -$27K
MSFT icon
246
Microsoft
MSFT
$3.71T
-7,592
Closed -$500K
MSFT icon
247
PUT
Microsoft
MSFT
$3.71T
-44,300
Closed -$21K
NEM icon
248
CALL
Newmont
NEM
$135B
-12,500
Closed -$6K
NEM icon
249
Newmont
NEM
$135B
-6,044
Closed -$199K
NEM icon
250
PUT
Newmont
NEM
$135B
-19,600
Closed -$22K

Similar funds

FT Options's Q2 2017 Portfolio in Review

As of Q2 2017, FT Options held 340 positions worth $58.1M, down 24% from $76M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

FT Options withdrew a net $21M in Q2 2017, closing 151 positions and reducing 56 holdings. Its most notable exit was Foot Locker, an estimated $2.12M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 37% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, FT Options opened a new position in Amgen worth $2.08M.

  • FT Options's largest Q2 2017 buy was Amgen: 12,082 shares worth $2.08M.
  • FT Options added most to Clovis Oncology, Inc. in Q2 2017, an estimated $2.31M increase.
  • FT Options's biggest Q2 2017 reduction was Abbott, cutting an estimated $5.02M.
  • FT Options fully exited Foot Locker in Q2 2017, selling an estimated $2.12M.
  • FT Options's ten largest holdings make up 44% of its $58.1M portfolio in Q2 2017.
  • FT Options opened 63 new positions and closed 151 in Q2 2017.
  • FT Options's portfolio value fell 24% quarter-over-quarter to $58.1M.

Based on FT Options's 13F filing for Q2 2017, filed 11 Aug 2017.